Epstein-Barr virus that lacks glycoprotein gN is impaired in assembly and infection

Journal of Virology

Volumn 74, Issue 23, 2000, Pages 11162-11172

  Lake, C M ^a   Hutt Fletcher, L M ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; NEOMYCIN; VIRUS PROTEIN;

ARTICLE; BURKITT LYMPHOMA; CELL MEMBRANE; CHROMATIN; EPSTEIN BARR VIRUS; HERPES VIRUS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; VIRUS ASSEMBLY; VIRUS CAPSID; VIRUS INFECTION; VIRUS RECOMBINANT;

B-LYMPHOCYTES; CELL LINE; DNA, VIRAL; HERPESVIRUS 4, HUMAN; OPEN READING FRAMES; RECEPTORS, VIRUS; RECOMBINATION, GENETIC; VIRAL ENVELOPE PROTEINS; VIRUS ASSEMBLY;

EID: 0034467233     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.23.11162-11172.2000     Document Type: Article

References (57)

1. Characterization of the protein encoded by the gene UL49A of herpes simplex virus type 1
2. DNA sequence and expression of the B95-8 Epstein-Barr virus genome
3. The open reading frames UL3, UL4, UL10, and UL16 are dispensible for the replication of herpes simplex virus 1 in cell culture
4. The UL10 gene of herpes simplex virus 1 encodes a novel viral glycoprotein, gM, which is present in the virion and in the plasma membrane of infected cells
5. The unique sequence of herpes simplex virus 1 L component contains an additional translated open reading frame designated UL49.5
6. Epstein-Barr virus recombinant lacking expression of glycoprotein gp150 infects B cells normally but is enhanced for infection of the epithelial line SVKCR2
7. Inhibition of virion maturation by simultaneous deletion of glycoproteins E, I, and M of pseudorabies virus
8. Role of the cytoplasmic tail of pseudorabies virus glycoprotein E in virion formation
9. Analysis of the contributions of herpes simplex virus type 1 membrane proteins to the induction of cell-cell fusion
10. Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells
11. Deletion of glycoprotein gM of pseudorabies virus results in attenuation for the natural host
12. Identification and characterization of pseudorabies virus glycoprotein gM as a nonessential virion component
13. The BFRF1 gene of Epstein-Barr virus encodes a novel protein
14. Neutralization epitope of the varicella-zoster virus gH-gL glycoprotein complex
15. Purification of biologically active Epstein-Barr virus by affinity chromatography and non-ionic density gradient centrifugation
16. DNA sequence of the UL6 to UL20 genes of infectious laryngotracheitis virus and characterization of the UL10 gene product as a non-glycosylated and nonessential virion protein
17. Neutralizing antibodies specific for glycoprotein H of herpes simplex virus permit viral attachment to cells but prevent penetration
18. Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis
19. The properties and sequence of glycoprotein H of herpes simplex type 1
20. Intracellular trafficking of two major Epstein-Barr virus glycoproteins, gp350/220 and gp110
21. New Epstein-Barr virus variants from cellular subclones of P3J-HR-1 Burkitt lymphoma
22. Monoclonal antibody against a 250,000-dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen
23. The human cytomegalovirus UL74 gene encodes the third component of the glycoprotein H-glycoprotein L-containing envelope complex
24. B cell activation and the establishment of Epstein-Barr virus latency
25. Glycoproteins M and N of pseudorabies virus form a disulfide-linked complex
26. The UL49.5 gene of pseudorabies virus codes for an O-glycosylated structural protein of the virus envelope
27. The human cytomegalovirus UL100 gene encodes the gC-II glycoproteins recognized by group 2 monoclonal antibodies
28. Identification and sequence of the gene encoding gpIII, a major glycoprotein of varicella-zoster virus
29. The Epstein-Barr virus (EBV) gN homolog BLRF1 encodes a 15 kilodalton glycoprotein that cannot be authentically processed unless it is co-expressed with the EBV gM homolog BBRF3
30. The Epstein-Barr virus glycoprotein 110 carboxy-terminal tail domain is essential for lytic virus replication
31. Identification and characterization of a human cytomegalovirus gene coding for a membrane protein that is conserved among human herpesviruses
32. Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes
33. The Epstein-Barr virus (EBV) BZLF2 gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells
34. Bovine herpesvirus 1 UL49.5 homolog gene encodes a novel viral envelope protein that forms a disulfide-linked complex with a second virion structural protein
35. Human herpesvirus 6 glycoprotein H and L homologues are components of the gp100 complex and the gH external domain is the target for neutralizing monoclonal antibodies
36. Characterization and expression of a glycoprotein encoded by the Epstein-Barr virus BamHI 1 fragment
37. Investigation of herpes simplex virus type 1 genes encoding multiply inserted membrane proteins
38. Characterization of the UL10 gene product of herpes simplex virus type 1 and investigations of its role in vivo
39. A monoclonal antibody to glycoprotein gp85 inhibits fusion but not attachment of Epstein-Barr virus
40. Epstein-Barr virus gH is essential for penetration of B cell but also plays a role in attachment of virus to epithelial cells
41. Equine herpesvirus 1 mutants devoid of glycoprotein B or M are apathogenic for mice but induce protection against challenge infection
42. The equine herpesvirus type 1 glycoprotein gp21/22a, the herpes simplex virus type 1 gM homolog, is involved in virus penetration and cell-to cell spread of virions
43. Synthesis and processing of the equine herpesvirus 1 glycoprotein M
44. Glycoprotein H of pseudorabies virus is essential for entry and cell-to-cell spread of the virus
45. Expression of Epstein-Barr virus BMRF-2 and BDLF-3 genes in hairy leukoplakia
46. Cytology of Burkitt's tumor (African lymphoma)
47. Herpes simplex virus type 1 dUTPase mutants are attenuated for neurovirulence, neuroinvasiveness, and reactivation from latency
48. L34 gene product is required for viral envelopment
49. Disruption of the varicellazoster virus dUTPase and the adjacent ORF9A gene results in impaired growth and reduced syncytia formation in vitro
50. Purification of herpes simplex virus type 1 by density gradient centrifugation and estimation of the sedimentation coefficient of the virion
51. Cross-linking of cell surface immunoglobulin induces Epstein-Barr virus in Burkitt lymphoma lines
52. An Epstein-Barr virus-producer line Akata: Establishment of the cell line and analysis of viral DNA
53. Epstein-Barr virus lacking glycoprotein gp42 can bind to B cells but is not able to infect
54. Epstein-Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells
55. L49.5 protein
56. Epstein-Barr virus glycoprotein gp85 associates with the BKRF2 gene product and is incompletely processed as a recombinant protein